Home
Aarti Drugs Ltd PE Ratio
![Image](/insights/_next/image?url=https%3A%2F%2Fstorage.googleapis.com%2Fassets.cdp.blinkx.in%2FBlinkx_Website%2Ficons%2Faarti-drugs-ltd.png&w=128&q=75)
Aarti Drugs Ltd
NSE: AARTIDRUGS
PE
Key Highlights
- The P/E Ratio of Aarti Drugs Ltd is 24.7 as of 15 Feb 9.00 AM .
- The P/E Ratio of Aarti Drugs Ltd changed from 8.3 on March 2020 to 23.3 on March 2024 . This represents a CAGR of 22.93% over 5 years.
- The Latest Trading Price of Aarti Drugs Ltd is ₹ 410.85 as of 14 Feb 15:30 .
- The PE Ratio of Pharmaceuticals Industry has changed from 21.0 to 40.0 in 5 years. This represents a CAGR of 13.75%.
- The PE Ratio of Automobile industry is 20.3. The PE Ratio of Finance industry is 17.8. The PE Ratio of IT - Software industry is 30.3. The PE Ratio of Pharmaceuticals industry is 40.0. The PE Ratio of Retail industry is 157.6. The PE Ratio of Textiles industry is 36.9 in 2024.
Historical P/E Ratio of Aarti Drugs Ltd
The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share. P/E Ratio Formula P/E ratio = (CMP of share/ Earning per share) Types of Price to Earning Ratio 1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance. 2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.
Historical P/E Ratio of Aarti Drugs Ltd
Company Fundamentals for Aarti Drugs Ltd
![Image](/insights/_next/image?url=https%3A%2F%2Fstorage.googleapis.com%2Fassets.cdp.blinkx.in%2FBlinkx_Website%2Ficons%2Faarti-drugs-ltd.png&w=128&q=75)
Aarti Drugs Ltd
NSE: AARTIDRUGS
Share Price
Market Price of Aarti Drugs Ltd
1M
1Y
3Y
5Y
Last Ten Days Market Price
Date | |
---|---|
14 Feb 2025 | 410.85 |
13 Feb 2025 | 383.25 |
12 Feb 2025 | 393.5 |
11 Feb 2025 | 393.75 |
10 Feb 2025 | 404.8 |
07 Feb 2025 | 415.65 |
06 Feb 2025 | 423.85 |
05 Feb 2025 | 417.05 |
04 Feb 2025 | 414.9 |
03 Feb 2025 | 424.4 |
SWOT Analysis Of Aarti Drugs Ltd
BlinkX Score for Aarti Drugs Ltd
Asset Value vs Market Value of Aarti Drugs Ltd
Market Value
₹ 0
Asset Value
₹ 0
* All values are in ₹ crores
Competitive Comparison of P/E Ratio
Company | Market Cap | PE Ratio |
---|
Aarti Drugs Ltd | 3777 | 24.74 |
Sun Pharmaceuticals Industries Ltd | 409003 | 34.7 |
Divis Laboratories Ltd | 154939 | 75.0 |
Cipla Ltd | 117835 | 23.6 |
Torrent Pharmaceuticals Ltd | 101918 | 54.7 |
Dr Reddys Laboratories Ltd | 99785 | 18.6 |
Company | |
---|---|
Aarti Drugs Ltd | 3777 |
Sun Pharmaceuticals Industries Ltd | 409003 |
Divis Laboratories Ltd | 154939 |
Cipla Ltd | 117835 |
Torrent Pharmaceuticals Ltd | 101918 |
Dr Reddys Laboratories Ltd | 99785 |
PE Ratio of Aarti Drugs Ltd Explained
₹3777
Market cap
₹152
Earnings
24.7X
PE Ratio
The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share.
P/E Ratio Formula
P/E ratio = (CMP of share/ Earning per share)
Types of Price to Earning Ratio
1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance.
2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.
PE Ratio of Pharmaceuticals Industry over time
PE Ratio of Top Sectors
Historical Market Cap of Aarti Drugs Ltd
Market Cap or market capitalisation refers to metrics that are used to measure a company's size. It is defined as the total market value of a company's outstanding shares of stock. Formula of Market Cap: Market Capital = N * P Here, N for the outstanding shares P refers to the closing price of the company's shares. Types of Companies based on Market Cap: - Small-Cap stocks: Up to 500 Crore - Mid-Cap Stocks: From Rs.500 crore up to Rs.7,000 crore - Large-Cap Stocks: From Rs.7,000 crore up to Rs.20,000 crore
Historical Market Cap of Aarti Drugs Ltd
Historical Revenue, EBITDA and Net Profit of Aarti Drugs Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services.\r\r\n\r\r\nTypes of Revenue:\r\r\n\r\r\n1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered.\r\r\n\r\r\n2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees.\r\r\n\r\r\nFormula for Revenue:\r\r\n\r\r\nThe formula for calculating revenue is based on two goods & services:\r\r\n\r\r\nFor goods:\r\r\nRevenue = Avg unit price x Number of Units sold\r\r\n\r\r\nFor services:\r\r\nRevenue = Avg unit price x Number of Customers served.PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions.\r\r\n\r\r\nNet Profit formula is expressed as:\r\r\n\r\r\nNet Profit = Total Revenue - Total Expense\r\r\n\r\r\nNet Profit Margin Ratio:\r\r\n\r\r\nNet Profit Margin Ratio = Net Profit / Total Revenue
Historical Revenue, EBITDA and Net Profit of Aarti Drugs Ltd
Revenue
EBITDA
Net Profit
Historical Dividend Payout of Aarti Drugs Ltd
Dividend payout refers to the total dividends paid to shareholders relative to the company's earnings. It is a financial measure that determines the percentage of earnings paid out to existing shareholders as dividends. How to calculate Dividend Payout Ratio? The dividend payout ratio formula is as follows: DPR = Dividends paid / Net earnings With the dividend payout ratio, you can understand the company's priorities. It is an important metric that allows you to easily check DPR online.
Historical Dividend Payout of Aarti Drugs Ltd
About Aarti Drugs Ltd
- Aarti Drugs Limited (ADL), incorporated in September, 1984 is a prominent manufacturer of APIs, Pharma Intermediates, and Specialty Chemicals.
- The Company operates as part of the Aarti Group, a conglomerate with a net worth of USD 900 million.
- With over 50 compounds for Antibiotics, Anti Protozoal, Anti-Inflammatory, Anti-diabetic, Anti Fungal and Cardioprotectant therapeutic segments, the Company has emerged as market leader in APIs.
- It has a wholly-owned subsidiary called Pinnacle Life Science Private Limited which operates in the field of manufacturing formulations. The Company has two R&D divisions, one in Tarapur and the other in Turbhe, Maharashtra.
- It has 3 subsidiaries, namely, Pinnacle Life Science Private Limited, Aarti Speciality Chemicals Limited and Pinnacle Chile SpA (foreign subsidiary).
Aarti Drugs Ltd News Hub
Aarti Drugs hit 52-week high as board OKs Rs 60-cr share buyback
The buyback price fixed at Rs 900 per equity share, representing a 59.66% premium to Friday's closin
Read more
26 Aug 24
Aarti Drugs to consider buyback
Aarti Drugs will hold a meeting of the Board of Directors of the Company on 26 August 2024. Powered
Read more
22 Aug 24
Aarti Drugs soars on share buyback proposal
The announcement was made after market hours yesterday. Aarti Drugs forms part of $6 Billion Aarti G
Read more
22 Aug 24
Board of Aarti Drugs approves buyback of shares up to Rs 59.85 cr
The Board of Aarti Drugs at its meeting held on 26 August 2024 has approved buyback of up to 6,65,00
Read more
26 Aug 24